METHOD FOR PREECLAMPSIA SEVERITY ASSESSMENT BY RELATIVE CONTENT OF CD16+ MONOCYTES IN PERIPHERAL BLOOD OF PREGNANT WOMEN Russian patent published in 2020 - IPC G01N33/00 G01N33/49 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to obstetrics and gynecology, and refers to a method for determining the severity of preeclampsia by relative CD16+ monocytes in peripheral blood of pregnant women. Method for determining preeclampsia severity by relative CD16+ monocyte content in peripheral blood of pregnant women consists in the fact that using flow cytofluorimetry in peripheral blood in pregnant women on various gestational periods after manifestation of clinical signs of preeclampsia severity of preeclampsia is determined by relative content of CD16+ monocytes, if the relative content of CD16+ monocytes is greater than or equal to 73.5 %, severe preeclampsia is verified, if less – moderate.

EFFECT: method described above enables to determine the severity of preeclampsia on various gestational periods.

1 cl, 3 ex